

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.28420827 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.28420827 |
| 3 | primary alcohol catabolic process (GO:0034310) | 7.12572103 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.97202710 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.97202710 |
| 6 | polyketide metabolic process (GO:0030638) | 6.69022205 |
| 7 | doxorubicin metabolic process (GO:0044598) | 6.69022205 |
| 8 | daunorubicin metabolic process (GO:0044597) | 6.69022205 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.61237727 |
| 10 | axonemal dynein complex assembly (GO:0070286) | 6.12135392 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.04453207 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.04453207 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.04453207 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.94930055 |
| 15 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.88339040 |
| 16 | * cysteine metabolic process (GO:0006534) | 5.81809467 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.71513640 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.71332143 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.67313641 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58694031 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.45724817 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.32253384 |
| 23 | urea metabolic process (GO:0019627) | 5.30933756 |
| 24 | urea cycle (GO:0000050) | 5.30933756 |
| 25 | lysine catabolic process (GO:0006554) | 5.20189715 |
| 26 | lysine metabolic process (GO:0006553) | 5.20189715 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.11789349 |
| 28 | ethanol metabolic process (GO:0006067) | 5.09238643 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 5.08851323 |
| 30 | protein carboxylation (GO:0018214) | 5.03034740 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.03034740 |
| 32 | complement activation, alternative pathway (GO:0006957) | 5.00607747 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.97099263 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.94138190 |
| 35 | iron ion import (GO:0097286) | 4.91391711 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.89097073 |
| 37 | bile acid metabolic process (GO:0008206) | 4.88313400 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 4.87134937 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.80731000 |
| 40 | high-density lipoprotein particle remodeling (GO:0034375) | 4.80044872 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.75248915 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.67956723 |
| 43 | regulation of complement activation (GO:0030449) | 4.64306215 |
| 44 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.52259344 |
| 45 | epoxygenase P450 pathway (GO:0019373) | 4.50024088 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.44759176 |
| 47 | ethanol oxidation (GO:0006069) | 4.42670023 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.40381373 |
| 49 | cellular glucuronidation (GO:0052695) | 4.36464241 |
| 50 | omega-hydroxylase P450 pathway (GO:0097267) | 4.32369149 |
| 51 | * glutamate metabolic process (GO:0006536) | 4.30295823 |
| 52 | glycoside metabolic process (GO:0016137) | 4.27030177 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.25806694 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 4.25406378 |
| 55 | drug transmembrane transport (GO:0006855) | 4.25195853 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.24313859 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.24313859 |
| 58 | reverse cholesterol transport (GO:0043691) | 4.23608493 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.22875617 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.21636218 |
| 61 | * serine family amino acid metabolic process (GO:0009069) | 4.21047449 |
| 62 | benzene-containing compound metabolic process (GO:0042537) | 4.19239216 |
| 63 | urate metabolic process (GO:0046415) | 4.18545216 |
| 64 | motile cilium assembly (GO:0044458) | 4.18132066 |
| 65 | triglyceride homeostasis (GO:0070328) | 4.17877833 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.17877833 |
| 67 | diterpenoid biosynthetic process (GO:0016102) | 4.17355267 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 4.17332687 |
| 69 | glycine metabolic process (GO:0006544) | 4.14273482 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.13495810 |
| 71 | drug catabolic process (GO:0042737) | 4.11816740 |
| 72 | plasma lipoprotein particle remodeling (GO:0034369) | 4.11520411 |
| 73 | protein-lipid complex remodeling (GO:0034368) | 4.11520411 |
| 74 | macromolecular complex remodeling (GO:0034367) | 4.11520411 |
| 75 | coenzyme catabolic process (GO:0009109) | 4.11142463 |
| 76 | regulation of cholesterol esterification (GO:0010872) | 4.10058467 |
| 77 | retinal metabolic process (GO:0042574) | 4.09153082 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 4.08575734 |
| 79 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.07856128 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 4.06326586 |
| 81 | amine catabolic process (GO:0009310) | 4.06326586 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 4.06001526 |
| 83 | progesterone metabolic process (GO:0042448) | 4.05812023 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02653300 |
| 85 | aldehyde catabolic process (GO:0046185) | 4.02590673 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 4.01074305 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.98732198 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.98732198 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 3.98172040 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 3.97002680 |
| 91 | glycosphingolipid catabolic process (GO:0046479) | 3.92536701 |
| 92 | phospholipid efflux (GO:0033700) | 3.92138926 |
| 93 | cholesterol efflux (GO:0033344) | 3.91456117 |
| 94 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.90174091 |
| 95 | short-chain fatty acid metabolic process (GO:0046459) | 3.85723414 |
| 96 | acetyl-CoA metabolic process (GO:0006084) | 3.84109044 |
| 97 | fibrinolysis (GO:0042730) | 3.75070547 |
| 98 | aspartate family amino acid catabolic process (GO:0009068) | 3.73820249 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 3.73739143 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72538255 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.69287717 |
| 102 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.66158235 |
| 103 | ketone body metabolic process (GO:1902224) | 3.65947170 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.64091431 |
| 105 | organic acid catabolic process (GO:0016054) | 3.64091431 |
| 106 | oligosaccharide catabolic process (GO:0009313) | 3.63823119 |
| 107 | cofactor catabolic process (GO:0051187) | 3.62953288 |
| 108 | exogenous drug catabolic process (GO:0042738) | 3.61912499 |
| 109 | glycolipid catabolic process (GO:0019377) | 3.61765944 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.55725615 |
| 111 | fatty acid oxidation (GO:0019395) | 3.55174532 |
| 112 | carnitine metabolic process (GO:0009437) | 3.54356914 |
| 113 | vitamin transmembrane transport (GO:0035461) | 3.53269133 |
| 114 | sterol homeostasis (GO:0055092) | 3.53172378 |
| 115 | positive regulation of extracellular matrix organization (GO:1903055) | 3.52455148 |
| 116 | arginine metabolic process (GO:0006525) | 3.50893834 |
| 117 | flavonoid metabolic process (GO:0009812) | 3.50315923 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.49066916 |
| 119 | 2-oxoglutarate metabolic process (GO:0006103) | 3.48580942 |
| 120 | fatty acid beta-oxidation (GO:0006635) | 3.48015375 |
| 121 | lipid oxidation (GO:0034440) | 3.47960909 |
| 122 | heme transport (GO:0015886) | 3.47105673 |
| 123 | primary alcohol metabolic process (GO:0034308) | 3.45944497 |
| 124 | drug transport (GO:0015893) | 3.45110288 |
| 125 | protein-lipid complex assembly (GO:0065005) | 3.44859846 |
| 126 | * response to nitrosative stress (GO:0051409) | 3.44023511 |
| 127 | low-density lipoprotein particle clearance (GO:0034383) | 3.42498844 |
| 128 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.41156619 |
| 129 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.37347957 |
| 130 | cilium movement (GO:0003341) | 3.34022496 |
| 131 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.33741125 |
| 132 | retinoic acid metabolic process (GO:0042573) | 3.27116387 |
| 133 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.24530049 |
| 134 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.22416283 |
| 135 | regulation of apoptotic cell clearance (GO:2000425) | 3.20978108 |
| 136 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.19115128 |
| 137 | regulation of cholesterol storage (GO:0010885) | 3.12669313 |
| 138 | ceramide catabolic process (GO:0046514) | 3.10012007 |
| 139 | negative regulation of humoral immune response (GO:0002921) | 2.97140763 |
| 140 | desmosome organization (GO:0002934) | 2.96671705 |
| 141 | cellular copper ion homeostasis (GO:0006878) | 2.94511352 |
| 142 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.93294262 |
| 143 | response to thyroid hormone (GO:0097066) | 2.92266639 |
| 144 | positive regulation of blood coagulation (GO:0030194) | 2.87256271 |
| 145 | positive regulation of hemostasis (GO:1900048) | 2.87256271 |
| 146 | positive regulation of coagulation (GO:0050820) | 2.86867282 |
| 147 | drug metabolic process (GO:0017144) | 2.86527145 |
| 148 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.86012912 |
| 149 | S-adenosylmethionine metabolic process (GO:0046500) | 2.86008774 |
| 150 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.85896219 |
| 151 | negative regulation of B cell mediated immunity (GO:0002713) | 2.85896219 |
| 152 | C21-steroid hormone metabolic process (GO:0008207) | 2.85061446 |
| 153 | cellular aldehyde metabolic process (GO:0006081) | 2.81480626 |
| 154 | porphyrin-containing compound metabolic process (GO:0006778) | 2.80917716 |
| 155 | hemidesmosome assembly (GO:0031581) | 2.80909885 |
| 156 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.80263589 |
| 157 | N-acetylneuraminate metabolic process (GO:0006054) | 2.79486360 |
| 158 | hemoglobin metabolic process (GO:0020027) | 2.79481902 |
| 159 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.79410614 |
| 160 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.79410614 |
| 161 | plasma lipoprotein particle organization (GO:0071827) | 2.73661987 |
| 162 | one-carbon compound transport (GO:0019755) | 2.70035826 |
| 163 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.67991514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.76032869 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.73305409 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21017660 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.18433189 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.73994670 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.51299693 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.45749169 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.36981771 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97865123 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.50511878 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.19971141 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15779968 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08398260 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04527898 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.03285218 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00135606 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8574757 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90873198 |
| 19 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.85285199 |
| 20 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.85285199 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.83961246 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.78248563 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77606747 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.58291580 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56702685 |
| 26 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44450778 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43921298 |
| 28 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.40441610 |
| 29 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.35003842 |
| 30 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.34681751 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34252327 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33452173 |
| 33 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28933340 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27919317 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24786272 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21775249 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20418054 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20139471 |
| 39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18899641 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14356157 |
| 41 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09834792 |
| 42 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08447114 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04734692 |
| 44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04057435 |
| 45 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03735343 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02551455 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00547953 |
| 48 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00453483 |
| 49 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.00258732 |
| 50 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99321805 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97714003 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97235186 |
| 53 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96294455 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95374597 |
| 55 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94915700 |
| 56 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.94712032 |
| 57 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93604115 |
| 58 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93565823 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93344956 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92907353 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92449827 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92196291 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91819738 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91160479 |
| 65 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91149076 |
| 66 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90555080 |
| 67 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90555080 |
| 68 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90136566 |
| 69 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89898507 |
| 70 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89187941 |
| 71 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88320845 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87087058 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83578218 |
| 74 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81590747 |
| 75 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.78280209 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77860222 |
| 77 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76851554 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76450718 |
| 79 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.75891180 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75762764 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.75617318 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75540593 |
| 83 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75227559 |
| 84 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75078510 |
| 85 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75033281 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73753218 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.72716052 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.70946849 |
| 89 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70699686 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.67934783 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.67839591 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67464270 |
| 93 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66180605 |
| 94 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.66010278 |
| 95 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64045108 |
| 96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63127063 |
| 97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62544146 |
| 98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61971008 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.61659087 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.61500695 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60276426 |
| 102 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59801098 |
| 103 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59228037 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.58631522 |
| 105 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.57694072 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57681527 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56906512 |
| 108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.55990000 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.55798007 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.55479092 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.54645122 |
| 112 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.53750669 |
| 113 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52223749 |
| 114 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.51935165 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.51356140 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.50612166 |
| 117 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49642048 |
| 118 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.48709645 |
| 119 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.48563869 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.47692127 |
| 121 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.47686830 |
| 122 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.46393704 |
| 123 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.46051885 |
| 124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.45791992 |
| 125 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.45263102 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.44830246 |
| 127 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.44449389 |
| 128 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.44449389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.06578820 |
| 2 | MP0005360_urolithiasis | 7.37237493 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.00959079 |
| 4 | MP0005365_abnormal_bile_salt | 5.70451365 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.03614653 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.03545643 |
| 7 | MP0003252_abnormal_bile_duct | 3.89782221 |
| 8 | MP0005083_abnormal_biliary_tract | 3.26877147 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.25818997 |
| 10 | MP0009840_abnormal_foam_cell | 2.88760841 |
| 11 | MP0005332_abnormal_amino_acid | 2.86011714 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.73272042 |
| 13 | MP0003195_calcinosis | 2.70493113 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.57019130 |
| 15 | MP0004147_increased_porphyrin_level | 2.51467968 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.42476147 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.33909455 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.04460601 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.00464217 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.75157572 |
| 21 | MP0003868_abnormal_feces_composition | 1.69115948 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.66166348 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.57361332 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55792051 |
| 25 | MP0000383_abnormal_hair_follicle | 1.40266918 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.38665796 |
| 27 | MP0003186_abnormal_redox_activity | 1.38169792 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.34123675 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.33256298 |
| 30 | MP0000858_altered_metastatic_potential | 1.32728279 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.27501081 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.22095772 |
| 33 | MP0003303_peritoneal_inflammation | 1.21335146 |
| 34 | MP0001764_abnormal_homeostasis | 1.21098733 |
| 35 | MP0000685_abnormal_immune_system | 1.19571229 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.19495680 |
| 37 | MP0002132_abnormal_respiratory_system | 1.18591290 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.18497024 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.17825638 |
| 40 | MP0002254_reproductive_system_inflammat | 1.16618364 |
| 41 | MP0005451_abnormal_body_composition | 1.14358462 |
| 42 | MP0000598_abnormal_liver_morphology | 1.12994700 |
| 43 | MP0000604_amyloidosis | 1.12254952 |
| 44 | MP0001216_abnormal_epidermal_layer | 1.11956400 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.09138743 |
| 46 | MP0003011_delayed_dark_adaptation | 1.08345218 |
| 47 | MP0005647_abnormal_sex_gland | 1.08293841 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.07095533 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.07095533 |
| 50 | MP0003632_abnormal_nervous_system | 1.04510572 |
| 51 | MP0009764_decreased_sensitivity_to | 1.02546787 |
| 52 | MP0008260_abnormal_autophagy | 0.97363877 |
| 53 | MP0002098_abnormal_vibrissa_morphology | 0.96805587 |
| 54 | MP0005310_abnormal_salivary_gland | 0.96533676 |
| 55 | MP0003950_abnormal_plasma_membrane | 0.92004650 |
| 56 | MP0002419_abnormal_innate_immunity | 0.91417283 |
| 57 | MP0008057_abnormal_DNA_replication | 0.90767410 |
| 58 | MP0001756_abnormal_urination | 0.89750655 |
| 59 | MP0009763_increased_sensitivity_to | 0.89741571 |
| 60 | MP0003941_abnormal_skin_development | 0.88807888 |
| 61 | MP0010155_abnormal_intestine_physiology | 0.87998766 |
| 62 | MP0002998_abnormal_bone_remodeling | 0.87930927 |
| 63 | MP0005408_hypopigmentation | 0.87175347 |
| 64 | MP0002136_abnormal_kidney_physiology | 0.87057745 |
| 65 | MP0005165_increased_susceptibility_to | 0.86875247 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.86647700 |
| 67 | MP0001915_intracranial_hemorrhage | 0.86327034 |
| 68 | MP0009785_altered_susceptibility_to | 0.85518264 |
| 69 | MP0008469_abnormal_protein_level | 0.84834252 |
| 70 | MP0009697_abnormal_copulation | 0.84595421 |
| 71 | MP0003690_abnormal_glial_cell | 0.84327713 |
| 72 | MP0003828_pulmonary_edema | 0.83449146 |
| 73 | MP0003300_gastrointestinal_ulcer | 0.82094972 |
| 74 | MP0002405_respiratory_system_inflammati | 0.81155882 |
| 75 | MP0005501_abnormal_skin_physiology | 0.80921008 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 0.80422564 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.80411779 |
| 78 | MP0004043_abnormal_pH_regulation | 0.78782816 |
| 79 | MP0000627_abnormal_mammary_gland | 0.78426828 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.78211560 |
| 81 | MP0001727_abnormal_embryo_implantation | 0.77535154 |
| 82 | MP0003329_amyloid_beta_deposits | 0.75922246 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.75796856 |
| 84 | MP0003634_abnormal_glial_cell | 0.74530557 |
| 85 | MP0000343_altered_response_to | 0.72329929 |
| 86 | MP0000762_abnormal_tongue_morphology | 0.71809722 |
| 87 | MP0005025_abnormal_response_to | 0.71705949 |
| 88 | MP0002796_impaired_skin_barrier | 0.70770025 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.69471093 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.68408105 |
| 91 | MP0002928_abnormal_bile_duct | 0.66345574 |
| 92 | MP0001853_heart_inflammation | 0.66034665 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.65863607 |
| 94 | MP0009931_abnormal_skin_appearance | 0.65060784 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.64405035 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.63823364 |
| 97 | MP0005220_abnormal_exocrine_pancreas | 0.62600830 |
| 98 | MP0006036_abnormal_mitochondrial_physio | 0.62427017 |
| 99 | MP0001661_extended_life_span | 0.61404992 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.61097737 |
| 101 | MP0002971_abnormal_brown_adipose | 0.60044872 |
| 102 | MP0005334_abnormal_fat_pad | 0.59927369 |
| 103 | MP0001849_ear_inflammation | 0.59284190 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.58896804 |
| 105 | MP0010307_abnormal_tumor_latency | 0.58328781 |
| 106 | MP0004130_abnormal_muscle_cell | 0.58098646 |
| 107 | MP0009053_abnormal_anal_canal | 0.58056459 |
| 108 | MP0003724_increased_susceptibility_to | 0.57887057 |
| 109 | MP0005166_decreased_susceptibility_to | 0.56719801 |
| 110 | MP0005464_abnormal_platelet_physiology | 0.56311724 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.54505571 |
| 112 | MP0005535_abnormal_body_temperature | 0.53703901 |
| 113 | MP0003075_altered_response_to | 0.52284715 |
| 114 | MP0008873_increased_physiological_sensi | 0.51532279 |
| 115 | MP0003436_decreased_susceptibility_to | 0.49698800 |
| 116 | MP0005266_abnormal_metabolism | 0.49194791 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.48249551 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.47816868 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.47609928 |
| 120 | MP0002168_other_aberrant_phenotype | 0.45923004 |
| 121 | MP0005395_other_phenotype | 0.45312013 |
| 122 | MP0008874_decreased_physiological_sensi | 0.45239366 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.42523537 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.42027510 |
| 125 | MP0004947_skin_inflammation | 0.41742355 |
| 126 | MP0006082_CNS_inflammation | 0.41696498 |
| 127 | MP0002295_abnormal_pulmonary_circulatio | 0.40232352 |
| 128 | MP0001177_atelectasis | 0.39526985 |
| 129 | MP0005164_abnormal_response_to | 0.39255510 |
| 130 | MP0001881_abnormal_mammary_gland | 0.39063854 |
| 131 | MP0006035_abnormal_mitochondrial_morpho | 0.38570807 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.37738140 |
| 133 | MP0005448_abnormal_energy_balance | 0.37302605 |
| 134 | MP0002135_abnormal_kidney_morphology | 0.37289106 |
| 135 | MP0008872_abnormal_physiological_respon | 0.37237799 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.36455920 |
| 137 | MP0000249_abnormal_blood_vessel | 0.35940539 |
| 138 | MP0001845_abnormal_inflammatory_respons | 0.34844806 |
| 139 | MP0004883_abnormal_blood_vessel | 0.33880365 |
| 140 | MP0005023_abnormal_wound_healing | 0.32448861 |
| 141 | MP0003953_abnormal_hormone_level | 0.32289957 |
| 142 | MP0008961_abnormal_basal_metabolism | 0.32105912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.05743140 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.75727005 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.68334997 |
| 4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.37669097 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.21871531 |
| 6 | Xanthomatosis (HP:0000991) | 5.83442061 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.71782631 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.42850883 |
| 9 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.05636746 |
| 10 | Rhinitis (HP:0012384) | 5.02548290 |
| 11 | Complement deficiency (HP:0004431) | 4.99279750 |
| 12 | Absent/shortened dynein arms (HP:0200106) | 4.91815851 |
| 13 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.91815851 |
| 14 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.90977247 |
| 15 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.90977247 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.78299791 |
| 17 | Nasal polyposis (HP:0100582) | 4.62075809 |
| 18 | Chronic bronchitis (HP:0004469) | 4.58699943 |
| 19 | Abnormal ciliary motility (HP:0012262) | 4.54146439 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.47794854 |
| 21 | Hyperammonemia (HP:0001987) | 4.24312082 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 4.24205088 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.24205088 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.24205088 |
| 25 | Epidermoid cyst (HP:0200040) | 4.21345089 |
| 26 | Hypolipoproteinemia (HP:0010981) | 4.18486031 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16213488 |
| 28 | Joint hemorrhage (HP:0005261) | 4.15713987 |
| 29 | Hyperglycinemia (HP:0002154) | 4.14872354 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 4.08954628 |
| 31 | Fat malabsorption (HP:0002630) | 4.07111511 |
| 32 | Ketosis (HP:0001946) | 4.02094513 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.00593160 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.99597947 |
| 35 | Hyperglycinuria (HP:0003108) | 3.98386702 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.92274915 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92274915 |
| 38 | Gout (HP:0001997) | 3.86304023 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.86121145 |
| 40 | Bronchiectasis (HP:0002110) | 3.72557322 |
| 41 | Abnormality of methionine metabolism (HP:0010901) | 3.66801386 |
| 42 | Abnormality of complement system (HP:0005339) | 3.61473717 |
| 43 | Hypoalphalipoproteinemia (HP:0003233) | 3.53266860 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 3.35510142 |
| 45 | Hypoglycemic coma (HP:0001325) | 3.32668217 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.31468483 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.28580516 |
| 48 | Hypercholesterolemia (HP:0003124) | 3.27215147 |
| 49 | Abnormality of the intrinsic pathway (HP:0010989) | 3.22964218 |
| 50 | Delayed CNS myelination (HP:0002188) | 3.21208172 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 3.18381127 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 3.14722933 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.14721264 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.12798020 |
| 55 | Hyperbilirubinemia (HP:0002904) | 3.12596455 |
| 56 | Ketoacidosis (HP:0001993) | 3.10647863 |
| 57 | Steatorrhea (HP:0002570) | 3.09650640 |
| 58 | Neurofibrillary tangles (HP:0002185) | 3.01118562 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.96562467 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.93737419 |
| 61 | Vascular calcification (HP:0004934) | 2.90248275 |
| 62 | Acanthocytosis (HP:0001927) | 2.87684801 |
| 63 | Myocardial infarction (HP:0001658) | 2.83725496 |
| 64 | Bronchitis (HP:0012387) | 2.83081486 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.81167772 |
| 66 | Metabolic acidosis (HP:0001942) | 2.76605033 |
| 67 | Thoracic kyphosis (HP:0002942) | 2.75689651 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.71816954 |
| 69 | Thick nail (HP:0001805) | 2.69536378 |
| 70 | Malnutrition (HP:0004395) | 2.69478878 |
| 71 | Spastic diplegia (HP:0001264) | 2.68980674 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.66139148 |
| 73 | Cholecystitis (HP:0001082) | 2.66139148 |
| 74 | Abnormality of serum amino acid levels (HP:0003112) | 2.64324249 |
| 75 | Hyperuricemia (HP:0002149) | 2.64006644 |
| 76 | Increased purine levels (HP:0004368) | 2.64006644 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.63831459 |
| 78 | Spontaneous abortion (HP:0005268) | 2.63733768 |
| 79 | Esophageal varix (HP:0002040) | 2.63226653 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.55437295 |
| 81 | Skin nodule (HP:0200036) | 2.54031224 |
| 82 | Flat acetabular roof (HP:0003180) | 2.53918074 |
| 83 | Increased serum ferritin (HP:0003281) | 2.52012630 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.50886127 |
| 85 | Abnormal gallbladder morphology (HP:0012437) | 2.48683376 |
| 86 | Cholelithiasis (HP:0001081) | 2.46853925 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44935621 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.44935621 |
| 89 | Disinhibition (HP:0000734) | 2.42605117 |
| 90 | Alkalosis (HP:0001948) | 2.42563579 |
| 91 | Recurrent otitis media (HP:0000403) | 2.40604536 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 2.40201904 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.39289487 |
| 94 | Male infertility (HP:0003251) | 2.35097351 |
| 95 | Rickets (HP:0002748) | 2.32235129 |
| 96 | Lethargy (HP:0001254) | 2.31749413 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31001990 |
| 98 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31001990 |
| 99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31001990 |
| 100 | Tetraparesis (HP:0002273) | 2.28861698 |
| 101 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28855637 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.27326795 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27326795 |
| 104 | Chronic otitis media (HP:0000389) | 2.26801063 |
| 105 | Mitral stenosis (HP:0001718) | 2.24955647 |
| 106 | Irritability (HP:0000737) | 2.24783890 |
| 107 | Neonatal onset (HP:0003623) | 2.23073623 |
| 108 | Global brain atrophy (HP:0002283) | 2.22905493 |
| 109 | Abnormality of the thoracic spine (HP:0100711) | 2.22441419 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 2.21441307 |
| 111 | Hydroxyprolinuria (HP:0003080) | 2.21441307 |
| 112 | Chronic sinusitis (HP:0011109) | 2.21083344 |
| 113 | Proximal tubulopathy (HP:0000114) | 2.20336977 |
| 114 | Poikilocytosis (HP:0004447) | 2.19637615 |
| 115 | Reticulocytosis (HP:0001923) | 2.14582970 |
| 116 | Recurrent sinusitis (HP:0011108) | 2.14477629 |
| 117 | Diaphragmatic weakness (HP:0009113) | 2.13416751 |
| 118 | Amyloidosis (HP:0011034) | 2.13260842 |
| 119 | Glomerulonephritis (HP:0000099) | 2.09423573 |
| 120 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.09254271 |
| 121 | Hypoglycemic seizures (HP:0002173) | 2.08772241 |
| 122 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.08347607 |
| 123 | Late onset (HP:0003584) | 2.05951417 |
| 124 | Loss of speech (HP:0002371) | 2.05493297 |
| 125 | Vomiting (HP:0002013) | 2.05120881 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 2.04603856 |
| 127 | Axonal loss (HP:0003447) | 2.00849471 |
| 128 | Hyperactive renin-angiotensin system (HP:0000841) | 1.99753572 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.99419858 |
| 130 | Infertility (HP:0000789) | 1.99054039 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 1.96141143 |
| 132 | Menorrhagia (HP:0000132) | 1.95137087 |
| 133 | Gingival bleeding (HP:0000225) | 1.94802342 |
| 134 | Enlarged kidneys (HP:0000105) | 1.93863089 |
| 135 | Pathologic fracture (HP:0002756) | 1.93442421 |
| 136 | Pancreatitis (HP:0001733) | 1.92550004 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91836699 |
| 138 | Thrombophlebitis (HP:0004418) | 1.90867318 |
| 139 | Interstitial pulmonary disease (HP:0006530) | 1.90502357 |
| 140 | Nephritis (HP:0000123) | 1.90214677 |
| 141 | Glomerulosclerosis (HP:0000096) | 1.89888700 |
| 142 | Back pain (HP:0003418) | 1.88451742 |
| 143 | Milia (HP:0001056) | 1.87890503 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.87105559 |
| 145 | Nausea (HP:0002018) | 1.86677422 |
| 146 | Brushfield spots (HP:0001088) | 1.85714893 |
| 147 | Tachypnea (HP:0002789) | 1.85348558 |
| 148 | Polycythemia (HP:0001901) | 1.85142233 |
| 149 | Hypophosphatemic rickets (HP:0004912) | 1.84955932 |
| 150 | Generalized aminoaciduria (HP:0002909) | 1.84626695 |
| 151 | Autoimmune thrombocytopenia (HP:0001973) | 1.83743498 |
| 152 | Coarse hair (HP:0002208) | 1.77955092 |
| 153 | Paralysis (HP:0003470) | 1.77780062 |
| 154 | Pustule (HP:0200039) | 1.77480614 |
| 155 | Hypoplasia of dental enamel (HP:0006297) | 1.77080406 |
| 156 | Metaphyseal irregularity (HP:0003025) | 1.77049133 |
| 157 | Abnormality of chloride homeostasis (HP:0011422) | 1.76780238 |
| 158 | Bone pain (HP:0002653) | 1.70885414 |
| 159 | Recurrent bacterial skin infections (HP:0005406) | 1.70031070 |
| 160 | Osteomalacia (HP:0002749) | 1.69539493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.49470242 |
| 2 | FGFR4 | 3.97095892 |
| 3 | ERN1 | 3.63619241 |
| 4 | SIK1 | 3.37285380 |
| 5 | ERBB4 | 2.86987450 |
| 6 | TAOK3 | 2.83498399 |
| 7 | MST1R | 2.76470507 |
| 8 | SMG1 | 2.36171757 |
| 9 | EPHA2 | 2.24955889 |
| 10 | EIF2AK1 | 2.23424058 |
| 11 | FGFR2 | 2.15196736 |
| 12 | EPHB1 | 1.99929521 |
| 13 | ACVR1B | 1.89050962 |
| 14 | PTK6 | 1.88584860 |
| 15 | LATS1 | 1.81234617 |
| 16 | TAOK2 | 1.81232241 |
| 17 | PRPF4B | 1.81138206 |
| 18 | WNK4 | 1.77993817 |
| 19 | NME2 | 1.77147469 |
| 20 | FRK | 1.76917213 |
| 21 | OXSR1 | 1.76169378 |
| 22 | TAOK1 | 1.72747654 |
| 23 | TRIB3 | 1.72208876 |
| 24 | CDK12 | 1.69398369 |
| 25 | PKN2 | 1.68831005 |
| 26 | MAP3K10 | 1.68673021 |
| 27 | MAP3K12 | 1.61422703 |
| 28 | PAK4 | 1.59883015 |
| 29 | TRPM7 | 1.59447033 |
| 30 | NEK6 | 1.56389809 |
| 31 | MAP2K4 | 1.56021284 |
| 32 | NEK9 | 1.55209652 |
| 33 | SCYL2 | 1.52239773 |
| 34 | MET | 1.52101721 |
| 35 | HIPK2 | 1.50845751 |
| 36 | MAPK11 | 1.49750256 |
| 37 | INSRR | 1.47936551 |
| 38 | WNK3 | 1.47598730 |
| 39 | AKT3 | 1.47345591 |
| 40 | DAPK2 | 1.42000389 |
| 41 | CDK6 | 1.41878765 |
| 42 | MAP3K3 | 1.39572440 |
| 43 | TYK2 | 1.38406458 |
| 44 | STK24 | 1.35745265 |
| 45 | MAP3K7 | 1.33302100 |
| 46 | GRK6 | 1.31662552 |
| 47 | ABL2 | 1.30533665 |
| 48 | RIPK1 | 1.30240784 |
| 49 | LRRK2 | 1.20263586 |
| 50 | CAMK1D | 1.15115588 |
| 51 | PTK2 | 1.13044808 |
| 52 | JAK2 | 1.11020288 |
| 53 | MAP3K2 | 1.10367721 |
| 54 | ERBB2 | 1.09244137 |
| 55 | PBK | 1.08486736 |
| 56 | GSK3A | 1.07606991 |
| 57 | STK10 | 1.07142593 |
| 58 | MAPK15 | 1.05282708 |
| 59 | FGR | 1.05133745 |
| 60 | FLT3 | 1.03646153 |
| 61 | JAK1 | 1.01343742 |
| 62 | EEF2K | 1.00123655 |
| 63 | CAMK1G | 0.99334833 |
| 64 | TBK1 | 0.98515204 |
| 65 | SGK3 | 0.97522294 |
| 66 | MAP2K3 | 0.96927192 |
| 67 | CAMKK2 | 0.96521320 |
| 68 | STK39 | 0.91932899 |
| 69 | TGFBR2 | 0.91644181 |
| 70 | TTK | 0.89931474 |
| 71 | DYRK1B | 0.89123847 |
| 72 | MAP3K14 | 0.87523140 |
| 73 | MATK | 0.87094807 |
| 74 | MAP3K9 | 0.86952280 |
| 75 | CHUK | 0.85860645 |
| 76 | STK3 | 0.84840983 |
| 77 | PRKAA2 | 0.84502551 |
| 78 | IKBKB | 0.83613276 |
| 79 | BMX | 0.81501652 |
| 80 | PIK3CG | 0.79537123 |
| 81 | ERBB3 | 0.78560554 |
| 82 | FGFR3 | 0.77494632 |
| 83 | LATS2 | 0.70390577 |
| 84 | CSK | 0.70201683 |
| 85 | SGK494 | 0.70016916 |
| 86 | SGK223 | 0.70016916 |
| 87 | MAPK4 | 0.69580667 |
| 88 | PDPK1 | 0.69347836 |
| 89 | EPHA3 | 0.68263188 |
| 90 | MAP2K2 | 0.67667300 |
| 91 | EIF2AK3 | 0.67269448 |
| 92 | STK38L | 0.66746161 |
| 93 | EGFR | 0.66513799 |
| 94 | MAP2K1 | 0.66354191 |
| 95 | PRKCZ | 0.64273018 |
| 96 | BRSK2 | 0.64149818 |
| 97 | KSR1 | 0.63363329 |
| 98 | MAPKAPK3 | 0.61842156 |
| 99 | MTOR | 0.60778524 |
| 100 | MAP3K11 | 0.60498560 |
| 101 | GRK7 | 0.59745571 |
| 102 | BMPR2 | 0.59702739 |
| 103 | PRKCQ | 0.59416578 |
| 104 | IRAK3 | 0.58731304 |
| 105 | FER | 0.57474895 |
| 106 | PDK2 | 0.57317836 |
| 107 | BRAF | 0.56916939 |
| 108 | ICK | 0.56775044 |
| 109 | CSNK1G1 | 0.55738389 |
| 110 | PRKACG | 0.53532667 |
| 111 | RET | 0.52649392 |
| 112 | PRKCI | 0.52296285 |
| 113 | KSR2 | 0.50787155 |
| 114 | CAMK2G | 0.49736180 |
| 115 | MAP3K13 | 0.49046210 |
| 116 | SGK2 | 0.47936620 |
| 117 | WNK1 | 0.47894049 |
| 118 | KDR | 0.47888784 |
| 119 | TGFBR1 | 0.44814163 |
| 120 | MAP3K1 | 0.44779352 |
| 121 | PAK3 | 0.44189449 |
| 122 | BRD4 | 0.44183502 |
| 123 | PRKAA1 | 0.43926457 |
| 124 | PDGFRB | 0.42824070 |
| 125 | MAP3K5 | 0.42761422 |
| 126 | CSNK1A1L | 0.40490745 |
| 127 | RPS6KB1 | 0.40254441 |
| 128 | ABL1 | 0.39999245 |
| 129 | CDK4 | 0.39597703 |
| 130 | PNCK | 0.39196295 |
| 131 | ZAP70 | 0.39078545 |
| 132 | NTRK1 | 0.38549781 |
| 133 | CDC42BPA | 0.37677555 |
| 134 | CSNK1G2 | 0.37425008 |
| 135 | MAPK12 | 0.37205617 |
| 136 | CSF1R | 0.36923160 |
| 137 | PDGFRA | 0.36404658 |
| 138 | MELK | 0.36307426 |
| 139 | PDK1 | 0.36306478 |
| 140 | PIM1 | 0.35843759 |
| 141 | MAP3K8 | 0.35527746 |
| 142 | LMTK2 | 0.35126215 |
| 143 | ARAF | 0.33977075 |
| 144 | MST4 | 0.33947998 |
| 145 | IKBKE | 0.32732196 |
| 146 | IGF1R | 0.31780467 |
| 147 | SGK1 | 0.31420378 |
| 148 | ALK | 0.29543323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.27934259 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.73035866 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.48801052 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12586637 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87010150 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74669411 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64855600 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62420076 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53908270 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52008779 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42306010 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41846400 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41006925 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30543097 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.26855397 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20318502 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.13268225 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98724447 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98277871 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94896471 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94846114 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88935456 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83641333 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76990941 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74189251 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73286426 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.70294926 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66788052 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66354565 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65850942 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63750281 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57407953 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54644280 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49021965 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48082130 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48002750 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41351502 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40819420 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29550140 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29151652 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.26318114 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26289898 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23433179 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22930308 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20863930 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19969825 |
| 47 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12967403 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12639054 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12497785 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09080129 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08107339 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04694966 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02147396 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01699950 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98418709 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.93459978 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92564266 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86246696 |
| 59 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.85647214 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84353396 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81798576 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80935605 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79490823 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74535995 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72268821 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69384491 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68340937 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67793925 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64754185 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63524389 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.48895554 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45357858 |
| 73 | Malaria_Homo sapiens_hsa05144 | 0.41530049 |
| 74 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.37738226 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36752295 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.36428083 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35565940 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35546158 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34365200 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.33417179 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33289147 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33212736 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.33019427 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32967772 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32759814 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.32520391 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29551623 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.26870292 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26506237 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.25793147 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.25373959 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24991886 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.24962787 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.23636107 |
| 95 | Leishmaniasis_Homo sapiens_hsa05140 | 0.18895909 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18321040 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17952450 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17177391 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.16253364 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16236237 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15756017 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.14418398 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.14358924 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.13679537 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07363345 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03375129 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.01672935 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00580435 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1998004 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1897606 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1853666 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1740194 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1621255 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1572072 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1415622 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1336639 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1334696 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1331575 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1249613 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | -0.1162635 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0973344 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0914235 |
| 123 | Lysosome_Homo sapiens_hsa04142 | -0.0629897 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0548470 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0389740 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0343189 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | -0.0217782 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | -0.0016652 |

